Cite
HARVARD Citation
Mato, A. et al. (n.d.). Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial. American journal of hematology. 93 (11), pp. 1394-1401. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mato, A. et al. (n.d.). Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial. American journal of hematology. 93 (11), pp. 1394-1401. [Online].